All Insights - Quantisnow Every item on the wire - press releases, filings, ratings, everything. https://quantisnow.com/news/all-insights en-us Mon, 27 Apr 2026 16:40:44 GMT Director Pelosi Peggie converted options into 1,057 shares and covered exercise/tax liability with 668 shares, increasing direct ownership by 8% to 5,364 units (SEC Form 4) 4 - USANA HEALTH SCIENCES INC (0000896264) (Issuer) https://quantisnow.com/insight/director-pelosi-peggie-converted-options-into-1057-shares-and-covered-6516037 https://quantisnow.com/insight/director-pelosi-peggie-converted-options-into-1057-shares-and-covered-6516037 Mon, 27 Apr 2026 16:36:24 GMT Director Fleming John Turman converted options into 1,057 shares, increasing direct ownership by 19% to 6,680 units (SEC Form 4) 4 - USANA HEALTH SCIENCES INC (0000896264) (Issuer) https://quantisnow.com/insight/director-fleming-john-turman-converted-options-into-1057-shares-increasing-6516036 https://quantisnow.com/insight/director-fleming-john-turman-converted-options-into-1057-shares-increasing-6516036 Mon, 27 Apr 2026 16:34:09 GMT Director Ding Xia converted options into 1,057 shares and covered exercise/tax liability with 391 shares, increasing direct ownership by 10% to 7,250 units (SEC Form 4) 4 - USANA HEALTH SCIENCES INC (0000896264) (Issuer) https://quantisnow.com/insight/director-ding-xia-converted-options-into-1057-shares-and-covered-6516035 https://quantisnow.com/insight/director-ding-xia-converted-options-into-1057-shares-and-covered-6516035 Mon, 27 Apr 2026 16:33:06 GMT Operating Officer Ueda Tatsuro was granted 85 shares (SEC Form 4) 4 - TOYOTA MOTOR CORP/ (0001094517) (Issuer) https://quantisnow.com/insight/operating-officer-ueda-tatsuro-was-granted-85-shares-sec-form-6516034 https://quantisnow.com/insight/operating-officer-ueda-tatsuro-was-granted-85-shares-sec-form-6516034 Mon, 27 Apr 2026 16:30:47 GMT Executive Fellow Tomoyama Shigeki was granted 14 shares (SEC Form 4) 4 - TOYOTA MOTOR CORP/ (0001094517) (Issuer) https://quantisnow.com/insight/executive-fellow-tomoyama-shigeki-was-granted-14-shares-sec-form-6516033 https://quantisnow.com/insight/executive-fellow-tomoyama-shigeki-was-granted-14-shares-sec-form-6516033 Mon, 27 Apr 2026 16:29:46 GMT Director Douglas Gary A. acquired $1,800 worth of shares (24 units at $74.27), increasing direct ownership by 0.27% to 9,027 units (SEC Form 4) 4 - Andersons, Inc. (0000821026) (Issuer) https://quantisnow.com/insight/director-douglas-gary-a-acquired-1800-worth-of-shares-24-6516032 https://quantisnow.com/insight/director-douglas-gary-a-acquired-1800-worth-of-shares-24-6516032 Mon, 27 Apr 2026 16:29:20 GMT Director Oshima Masahiko was granted 71 shares (SEC Form 4) 4 - TOYOTA MOTOR CORP/ (0001094517) (Issuer) https://quantisnow.com/insight/director-oshima-masahiko-was-granted-71-shares-sec-form-4-6516031 https://quantisnow.com/insight/director-oshima-masahiko-was-granted-71-shares-sec-form-4-6516031 Mon, 27 Apr 2026 16:28:27 GMT SEC Form 4 filed by Director Hershberger Pamela S 4 - Andersons, Inc. (0000821026) (Issuer) https://quantisnow.com/insight/sec-form-4-filed-by-director-hershberger-pamela-s-6516030 https://quantisnow.com/insight/sec-form-4-filed-by-director-hershberger-pamela-s-6516030 Mon, 27 Apr 2026 16:28:40 GMT Director Osada Hiromi was granted 28 shares (SEC Form 4) 4 - TOYOTA MOTOR CORP/ (0001094517) (Issuer) https://quantisnow.com/insight/director-osada-hiromi-was-granted-28-shares-sec-form-4-6516029 https://quantisnow.com/insight/director-osada-hiromi-was-granted-28-shares-sec-form-4-6516029 Mon, 27 Apr 2026 16:27:08 GMT Director Bruggeman Brett W was granted 1,119 shares and covered exercise/tax liability with 283 shares, increasing direct ownership by 31% to 3,566 units (SEC Form 4) (withholding obligation) 4 - SENSIENT TECHNOLOGIES CORP (0000310142) (Issuer) https://quantisnow.com/insight/director-bruggeman-brett-w-was-granted-1119-shares-and-covered-6516028 https://quantisnow.com/insight/director-bruggeman-brett-w-was-granted-1119-shares-and-covered-6516028 Mon, 27 Apr 2026 16:25:39 GMT Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules DETROIT, April 27, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced that it has entered into definitive agreements for the purchase and sale of 696,866 shares of its common stock, at a purchase price of $1.435 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, the Company has agreed to issue to the investor unregistered Series A-1 warrants to purchase up to 696,866 shares of common stock and unregistered Series A-2 warrants to purchase up to 696,866 shares of common stock. The warrants will have an exercise price of $1.435 per share and will be exerci https://quantisnow.com/insight/amesite-announces-up-to-6-million-concurrent-registered-direct-offering-6516027 https://quantisnow.com/insight/amesite-announces-up-to-6-million-concurrent-registered-direct-offering-6516027 Mon, 27 Apr 2026 16:25:01 GMT Director Olcott George Cunningham was granted 71 shares (SEC Form 4) 4 - TOYOTA MOTOR CORP/ (0001094517) (Issuer) https://quantisnow.com/insight/director-olcott-george-cunningham-was-granted-71-shares-sec-form-6516026 https://quantisnow.com/insight/director-olcott-george-cunningham-was-granted-71-shares-sec-form-6516026 Mon, 27 Apr 2026 16:22:29 GMT Director Okamoto Shigeaki was granted 86 shares (SEC Form 4) 4 - TOYOTA MOTOR CORP/ (0001094517) (Issuer) https://quantisnow.com/insight/director-okamoto-shigeaki-was-granted-86-shares-sec-form-4-6516025 https://quantisnow.com/insight/director-okamoto-shigeaki-was-granted-86-shares-sec-form-4-6516025 Mon, 27 Apr 2026 16:19:00 GMT Tompkins Financial Corporation filed SEC Form 8-K: Leadership Update 8-K - TOMPKINS FINANCIAL CORP (0001005817) (Filer) https://quantisnow.com/insight/tompkins-financial-corporation-filed-sec-form-8-k-leadership-update-6516024 https://quantisnow.com/insight/tompkins-financial-corporation-filed-sec-form-8-k-leadership-update-6516024 Mon, 27 Apr 2026 16:17:16 GMT Director Carleone Joseph was granted 1,119 shares, increasing direct ownership by 5% to 23,670 units (SEC Form 4) 4 - SENSIENT TECHNOLOGIES CORP (0000310142) (Issuer) https://quantisnow.com/insight/director-carleone-joseph-was-granted-1119-shares-increasing-direct-ownership-6516023 https://quantisnow.com/insight/director-carleone-joseph-was-granted-1119-shares-increasing-direct-ownership-6516023 Mon, 27 Apr 2026 16:16:57 GMT Director Ferruzzi Mario was granted 1,119 shares and covered exercise/tax liability with 674 shares, increasing direct ownership by 6% to 8,521 units (SEC Form 4) (tax withholding) 4 - SENSIENT TECHNOLOGIES CORP (0000310142) (Issuer) https://quantisnow.com/insight/director-ferruzzi-mario-was-granted-1119-shares-and-covered-exercisetax-6516022 https://quantisnow.com/insight/director-ferruzzi-mario-was-granted-1119-shares-and-covered-exercisetax-6516022 Mon, 27 Apr 2026 16:15:35 GMT Executive Fellow Kawai Mitsuru was granted 100 shares (SEC Form 4) 4 - TOYOTA MOTOR CORP/ (0001094517) (Issuer) https://quantisnow.com/insight/executive-fellow-kawai-mitsuru-was-granted-100-shares-sec-form-6516021 https://quantisnow.com/insight/executive-fellow-kawai-mitsuru-was-granted-100-shares-sec-form-6516021 Mon, 27 Apr 2026 16:13:10 GMT SEC Form 10-Q filed by Noble Corporation plc A 10-Q - Noble Corp plc (0001895262) (Filer) https://quantisnow.com/insight/sec-form-10-q-filed-by-noble-corporation-plc-a-6516020 https://quantisnow.com/insight/sec-form-10-q-filed-by-noble-corporation-plc-a-6516020 Mon, 27 Apr 2026 16:14:08 GMT Director Jackson Carol R covered exercise/tax liability with 674 shares and was granted 1,119 shares, increasing direct ownership by 7% to 6,540 units (SEC Form 4) to satisfy tax liability 4 - SENSIENT TECHNOLOGIES CORP (0000310142) (Issuer) https://quantisnow.com/insight/director-jackson-carol-r-covered-exercisetax-liability-with-674-shares-6516019 https://quantisnow.com/insight/director-jackson-carol-r-covered-exercisetax-liability-with-674-shares-6516019 Mon, 27 Apr 2026 16:13:46 GMT SEC Form S-8 filed by PNC Financial Services Group Inc. S-8 - PNC FINANCIAL SERVICES GROUP, INC. (0000713676) (Filer) https://quantisnow.com/insight/sec-form-s-8-filed-by-pnc-financial-services-group-inc-6516018 https://quantisnow.com/insight/sec-form-s-8-filed-by-pnc-financial-services-group-inc-6516018 Mon, 27 Apr 2026 16:12:09 GMT Director Jain Sharad P was granted 1,119 shares, increasing direct ownership by 19% to 6,997 units (SEC Form 4) 4 - SENSIENT TECHNOLOGIES CORP (0000310142) (Issuer) https://quantisnow.com/insight/director-jain-sharad-p-was-granted-1119-shares-increasing-direct-6516017 https://quantisnow.com/insight/director-jain-sharad-p-was-granted-1119-shares-increasing-direct-6516017 Mon, 27 Apr 2026 16:12:08 GMT American Rebel Holdings (NASDAQ: AREB) Announces Nasdaq Trading Resumption and Provides Shareholder Update NASHVILLE, TN / ACCESS Newswire / April 27, 2026 / American Rebel Holdings, Inc. (NASDAQ:AREB)(NASDAQ:AREBW) ("American Rebel" or the "Company") today acknowledged Nasdaq's announcement that trading in the Company's common stock and publicly traded warrants will resume at 11:00 a.m. Eastern Time on April 27, 2026. Trading in AREB and AREBW had been halted by Nasdaq on March 20, 2026 at 7:50 p.m. Eastern Time."We appreciate Nasdaq's resumption of trading and the continued support of our shareholders during this process," said Andy Ross, Chief Executive Officer of American Rebel. "The shares issued to CEDE & Co. for distribution to stockholders affected by the round-lot rounding were an import https://quantisnow.com/insight/american-rebel-holdings-nasdaq-areb-announces-nasdaq-trading-resumption-and-6516016 https://quantisnow.com/insight/american-rebel-holdings-nasdaq-areb-announces-nasdaq-trading-resumption-and-6516016 Mon, 27 Apr 2026 16:10:00 GMT Operating Officer Imura Takahiro was granted 57 shares (SEC Form 4) 4 - TOYOTA MOTOR CORP/ (0001094517) (Issuer) https://quantisnow.com/insight/operating-officer-imura-takahiro-was-granted-57-shares-sec-form-6516015 https://quantisnow.com/insight/operating-officer-imura-takahiro-was-granted-57-shares-sec-form-6516015 Mon, 27 Apr 2026 16:08:12 GMT Director Morrison Scott C was granted 1,119 shares and covered exercise/tax liability with 674 shares, increasing direct ownership by 4% to 11,546 units (SEC Form 4) (tax withholding) 4 - SENSIENT TECHNOLOGIES CORP (0000310142) (Issuer) https://quantisnow.com/insight/director-morrison-scott-c-was-granted-1119-shares-and-covered-6516014 https://quantisnow.com/insight/director-morrison-scott-c-was-granted-1119-shares-and-covered-6516014 Mon, 27 Apr 2026 16:05:45 GMT SEC Form 8-A12B filed by Greenland Energy Company 8-A12B - Greenland Energy Co (0002093507) (Filer) https://quantisnow.com/insight/sec-form-8-a12b-filed-by-greenland-energy-company-6516013 https://quantisnow.com/insight/sec-form-8-a12b-filed-by-greenland-energy-company-6516013 Mon, 27 Apr 2026 16:05:13 GMT Director Whitelaw Essie was granted 1,119 shares and covered exercise/tax liability with 674 shares, increasing direct ownership by 3% to 17,584 units (SEC Form 4) (withholding obligation) 4 - SENSIENT TECHNOLOGIES CORP (0000310142) (Issuer) https://quantisnow.com/insight/director-whitelaw-essie-was-granted-1119-shares-and-covered-exercisetax-6516012 https://quantisnow.com/insight/director-whitelaw-essie-was-granted-1119-shares-and-covered-exercisetax-6516012 Mon, 27 Apr 2026 16:04:02 GMT SEC Form 6-K filed by Shell PLC 6-K - Shell plc (0001306965) (Filer) https://quantisnow.com/insight/sec-form-6-k-filed-by-shell-plc-6516011 https://quantisnow.com/insight/sec-form-6-k-filed-by-shell-plc-6516011 Mon, 27 Apr 2026 16:03:30 GMT MACOM to Enter into Agreements to Further Strengthen Supply Chain LOWELL, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Inc. ("MACOM"), a leading supplier of semiconductor products, today announced that it will enter into Long-Term Supply Agreements ("LTSAs") with IQE plc ("IQE") for epitaxial services spanning multiple technologies. The LTSAs are expected to further secure supply in support of MACOM's growth strategy. In parallel with the LTSAs, subject to customary closing conditions, including obtaining certain regulatory clearances, MACOM will participate in a financing transaction with IQE. MACOM's proposed investment in IQE will total £45 million, in the form of equity and a convertible loan note. As part of the investment, https://quantisnow.com/insight/macom-to-enter-into-agreements-to-further-strengthen-supply-chain-6516010 https://quantisnow.com/insight/macom-to-enter-into-agreements-to-further-strengthen-supply-chain-6516010 Mon, 27 Apr 2026 16:00:29 GMT Perini Management Services, Inc. Awarded the Right to Compete for Task Orders Under $2 Billion USACE Energy Resilience and Conservation Investment Program Tutor Perini Corporation (NYSE:TPC) (the "Company"), a leading civil, building and specialty construction company, announced today that its subsidiary, Perini Management Services, Inc. ("PMSI"), has been awarded a construction multiple-award task order contract ("MATOC") by the U.S. Army Corps of Engineers ("USACE"), Louisville District. The contract provides a shared capacity of $2 billion over 10 years (a three-year base period and seven one-year option periods) for design-build and design-bid-build construction services supporting the Energy Resilience and Conservation Investment Program ("ERCIP") nationwide. This MATOC enables PMSI to compete for task orders under the ERCIP, and the s https://quantisnow.com/insight/perini-management-services-inc-awarded-the-right-to-compete-for-6516009 https://quantisnow.com/insight/perini-management-services-inc-awarded-the-right-to-compete-for-6516009 Mon, 27 Apr 2026 16:00:00 GMT Forrester: The GTM Singularity Is Collapsing Traditional Go-To-Market Approaches Unveiled at B2B Summit North America, Forrester's GTM singularity research urges B2B leaders to shed old go-to-market principles as buying gets more complex Forrester's (NASDAQ:FORR) latest research, The GTM Singularity Is Here, unveiled today at B2B Summit North America, is a clarion call to B2B leaders across marketing, sales, customer success, and product functions to finally discard decades-old go-to-market (GTM) practices and embrace a new ARC (augmented, resilient, and collaborative) GTM approach that engages today's AI-enabled buyers and customers. Despite years of volatility driven by changing buyer behavior and unprecedented information access, B2B firms have failed to change h https://quantisnow.com/insight/forrester-the-gtm-singularity-is-collapsing-traditional-go-to-market-approaches-6516008 https://quantisnow.com/insight/forrester-the-gtm-singularity-is-collapsing-traditional-go-to-market-approaches-6516008 Mon, 27 Apr 2026 16:00:00 GMT The Governance Institute Releases Falling Behind Report, Warning Health System Operations Are Advancing Faster than Governance Released during TGI's 250th Leadership Conference, the report calls for a redesign of governance to match the complexity of modern healthcare. The Governance Institute (TGI), a service of NRC Health, today released Falling Behind: Health System Operations Are Advancing Faster than Governance, a new governance brief examining whether today's health system governance models are keeping pace with the scale, complexity, and speed of modern healthcare. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427225909/en/The Governance Institute (TGI), a service of NRC Health, today released Falling Behind: Health system operations are ad https://quantisnow.com/insight/the-governance-institute-releases-falling-behind-report-warning-health-system-6516007 https://quantisnow.com/insight/the-governance-institute-releases-falling-behind-report-warning-health-system-6516007 Mon, 27 Apr 2026 15:59:00 GMT Director Fujisawa Kumi was granted 29 shares (SEC Form 4) 4 - TOYOTA MOTOR CORP/ (0001094517) (Issuer) https://quantisnow.com/insight/director-fujisawa-kumi-was-granted-29-shares-sec-form-4-6516006 https://quantisnow.com/insight/director-fujisawa-kumi-was-granted-29-shares-sec-form-4-6516006 Mon, 27 Apr 2026 15:56:48 GMT LGI Homes Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits 8-K - LGI Homes, Inc. (0001580670) (Filer) https://quantisnow.com/insight/lgi-homes-inc-filed-sec-form-8-k-submission-of-matters-6516005 https://quantisnow.com/insight/lgi-homes-inc-filed-sec-form-8-k-submission-of-matters-6516005 Mon, 27 Apr 2026 15:55:06 GMT Senior Fellow Asakura Masashi was granted 57 shares (SEC Form 4) 4 - TOYOTA MOTOR CORP/ (0001094517) (Issuer) https://quantisnow.com/insight/senior-fellow-asakura-masashi-was-granted-57-shares-sec-form-6516004 https://quantisnow.com/insight/senior-fellow-asakura-masashi-was-granted-57-shares-sec-form-6516004 Mon, 27 Apr 2026 15:54:47 GMT SEC Form FWP filed by JP Morgan Chase & Co. FWP - JPMORGAN CHASE & CO (0000019617) (Subject) https://quantisnow.com/insight/sec-form-fwp-filed-by-jp-morgan-chase-co-6516003 https://quantisnow.com/insight/sec-form-fwp-filed-by-jp-morgan-chase-co-6516003 Mon, 27 Apr 2026 15:53:47 GMT Amendment: SEC Form S-3/A filed by PDS Biotechnology Corporation S-3/A - PDS Biotechnology Corp (0001472091) (Filer) https://quantisnow.com/insight/amendment-sec-form-s-3a-filed-by-pds-biotechnology-corporation-6516002 https://quantisnow.com/insight/amendment-sec-form-s-3a-filed-by-pds-biotechnology-corporation-6516002 Mon, 27 Apr 2026 15:51:40 GMT Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal WARREN, N.J., April 27, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) today announced continued progress within its artificial intelligence initiative, Tevogen.AI, including the near completion of its PredicTcell™ training algorithm and early steps toward commercial readiness. PredicTcell™, Tevogen.AI's proprietary machine learning model designed to identify immunologically active peptides, is approaching the final stages of its training phase. The model has been trained on one of the industry's largest curated peptide datasets, with feature expansion now exceeding 180 parameters, contributing to an approximate 10% improvement in precision. As https://quantisnow.com/insight/tevogenai-nears-completion-of-predictcell-training-initiates-commercial-readiness-and-6516001 https://quantisnow.com/insight/tevogenai-nears-completion-of-predictcell-training-initiates-commercial-readiness-and-6516001 Mon, 27 Apr 2026 15:49:59 GMT SEC Form POS AM filed by Amicus Therapeutics Inc. POS AM - AMICUS THERAPEUTICS, INC. (0001178879) (Filer) https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6516000 https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6516000 Mon, 27 Apr 2026 15:47:18 GMT SEC Form 6-K filed by RELX PLC PLC 6-K - RELX PLC (0000929869) (Filer) https://quantisnow.com/insight/sec-form-6-k-filed-by-relx-plc-plc-6515999 https://quantisnow.com/insight/sec-form-6-k-filed-by-relx-plc-plc-6515999 Mon, 27 Apr 2026 15:46:52 GMT SEC Form POS AM filed by Amicus Therapeutics Inc. POS AM - AMICUS THERAPEUTICS, INC. (0001178879) (Filer) https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6515998 https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6515998 Mon, 27 Apr 2026 15:47:17 GMT SEC Form POS AM filed by Amicus Therapeutics Inc. POS AM - AMICUS THERAPEUTICS, INC. (0001178879) (Filer) https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6515997 https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6515997 Mon, 27 Apr 2026 15:47:19 GMT SEC Form POS AM filed by Amicus Therapeutics Inc. POS AM - AMICUS THERAPEUTICS, INC. (0001178879) (Filer) https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6515996 https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6515996 Mon, 27 Apr 2026 15:47:19 GMT SEC Form POS AM filed by Amicus Therapeutics Inc. POS AM - AMICUS THERAPEUTICS, INC. (0001178879) (Filer) https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6515995 https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6515995 Mon, 27 Apr 2026 15:47:17 GMT SEC Form POS AM filed by Amicus Therapeutics Inc. POS AM - AMICUS THERAPEUTICS, INC. (0001178879) (Filer) https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6515994 https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6515994 Mon, 27 Apr 2026 15:47:18 GMT SEC Form POS AM filed by Amicus Therapeutics Inc. POS AM - AMICUS THERAPEUTICS, INC. (0001178879) (Filer) https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6515993 https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6515993 Mon, 27 Apr 2026 15:47:20 GMT SEC Form POS AM filed by Amicus Therapeutics Inc. POS AM - AMICUS THERAPEUTICS, INC. (0001178879) (Filer) https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6515992 https://quantisnow.com/insight/sec-form-pos-am-filed-by-amicus-therapeutics-inc-6515992 Mon, 27 Apr 2026 15:47:20 GMT SEC Form 6-K filed by POET Technologies Inc. 6-K - POET TECHNOLOGIES INC. (0001437424) (Filer) https://quantisnow.com/insight/sec-form-6-k-filed-by-poet-technologies-inc-6515991 https://quantisnow.com/insight/sec-form-6-k-filed-by-poet-technologies-inc-6515991 Mon, 27 Apr 2026 15:45:59 GMT Amicus Therapeutics Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits 8-K - AMICUS THERAPEUTICS, INC. (0001178879) (Filer) https://quantisnow.com/insight/amicus-therapeutics-inc-filed-sec-form-8-k-termination-of-a-6515990 https://quantisnow.com/insight/amicus-therapeutics-inc-filed-sec-form-8-k-termination-of-a-6515990 Mon, 27 Apr 2026 15:43:25 GMT Frontier Group Holdings Announces Webcast of First Quarter 2026 Financial Results DENVER, April 27, 2026 /PRNewswire/ -- Frontier Group Holdings, Inc. (NASDAQ:ULCC), parent company of Frontier Airlines, Inc., will be releasing its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026. Management will host a live webcast with analysts to discuss these results the same day at 11:00am ET. The webcast will be available to the public on a listen-only basis at http://ir.flyfrontier.com.A replay of the call will be archived on the company's Investor Relations website for 30 days.About Frontier AirlinesFrontier Airlines, Inc., a subsidi https://quantisnow.com/insight/frontier-group-holdings-announces-webcast-of-first-quarter-2026-financial-6515989 https://quantisnow.com/insight/frontier-group-holdings-announces-webcast-of-first-quarter-2026-financial-6515989 Mon, 27 Apr 2026 15:40:00 GMT Large owner Horizon Kinetics Asset Management Llc bought $435 worth of shares (1 units at $435.40), increasing direct ownership by 0.00% to 3,435,504 units (SEC Form 4) 4 - Texas Pacific Land Corp (0001811074) (Issuer) https://quantisnow.com/insight/large-owner-horizon-kinetics-asset-management-llc-bought-435-worth-6515988 https://quantisnow.com/insight/large-owner-horizon-kinetics-asset-management-llc-bought-435-worth-6515988 Mon, 27 Apr 2026 15:36:45 GMT